🔍

UTIAMC - UTI AMC

📊 NSE: UTIAMC 🏢 Finance & Investments 📅 Last Updated: 12/14/2025 14:48

📢 Recent Corporate Announcements

UTI AMC to Meet Motilal Oswal Financial Services on May 15, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 29 Apr 2026, 04:00 PM

UTI Asset Management Company Limited has scheduled a one-on-one meeting with Motilal Oswal Financial Services Limited. The meeting is slated for May 15, 2026, at 16:00 hrs IST at the company's corporate office in Mumbai. This disclosure is a routine compliance filing under Regulation 30 of SEBI (LODR) Regulations, 2015. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during this interaction.

One-on-one meeting scheduled with Motilal Oswal Financial Services Limited.
Meeting date set for May 15, 2026, at 4:00 PM IST.
Interaction will be held in person at the Corporate Office in BKC, Mumbai.
Company confirms that no Unpublished Price Sensitive Information (UPSI) will be shared.

💡 No immediate action is required as this is a routine investor engagement. Investors may look for any post-meeting presentations or transcripts if the company chooses to publish them.

UTI AMC Schedules One-on-One Meeting with Kotak Securities on May 14

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 29 Apr 2026, 03:56 PM

UTI Asset Management Company Limited (UTIAMC) has announced a scheduled meeting with Kotak Securities Limited on May 14, 2026. The meeting will be held in-person at the company's corporate office in Mumbai at 14:00 hrs IST. This is a one-on-one interaction between the senior management and the institutional investor. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during the discussion.

Meeting with Kotak Securities Limited scheduled for May 14, 2026, at 14:00 hrs IST.
The interaction will be conducted in-person at the UTI AMC Corporate Office in BKC, Mumbai.
The meeting is designated as a one-on-one session with senior management.
The company clarified that no Unpublished Price Sensitive Information (UPSI) will be disclosed.

💡 This is a routine disclosure with no immediate impact on stock price. Investors should watch for any subsequent research reports from Kotak Securities that might provide qualitative insights into the company's strategy.

UTI AMC FY26 Results: Group AUM Reaches ₹23.42 Lakh Cr; Consolidated Core Income Up 6.5%

🟡 NEUTRAL ⭐ 8/10

EARNINGS 📅 28 Apr 2026, 02:45 PM

UTI AMC reported a steady growth in its Mutual Fund AUM to ₹3.88 lakh crores for FY26, driven by strong SIP inflows and digital adoption. While consolidated core income rose to ₹1,539 crores from ₹1,445 crores, normalized consolidated PAT saw a decline to ₹511 crores compared to ₹731 crores in the previous year. The company successfully renewed major institutional mandates with EPFO and CMPFO for five-year terms, ensuring long-term institutional stability. The pension fund subsidiary remains a high-growth area, managing over ₹4 lakh crores in assets with an 11.8% YoY growth.

Group AUM stood at ₹23.42 lakh crores, with Mutual Fund AUM growing to ₹3.88 lakh crores in FY26.
Consolidated core income from services increased to ₹1,539 crores, while normalized employee costs stood at ₹528 crores.
SIP inflows for the full year reached ₹9,442 crores, marking a 13.42% year-on-year growth with 76% registrations via digital channels.
Successfully secured 5-year portfolio management mandates from EPFO and CMPFO through open bidding.
UTI Pension Fund AUM reached ₹4.02 lakh crores, representing 24.36% of the total NPS industry AUM.

💡 Investors should monitor the company's ability to improve profit margins as AUM scales, particularly given the decline in consolidated PAT. The retention of large institutional mandates and growth in the high-margin pension business are key positives to watch.

UTI AMC Releases Audio Recording of Q4 & FY26 Earnings Conference Call

🟡 NEUTRAL ⭐ 4/10

EARNINGS 📅 23 Apr 2026, 09:52 PM

UTI Asset Management Company Limited (UTIAMC) has released the audio recording of its earnings conference call held on April 23, 2026. The call discussed the company's financial performance for the fourth quarter and the full financial year ending March 31, 2026. This disclosure is a routine regulatory requirement under SEBI Listing Regulations to ensure transparency for all shareholders. Investors can access the recording on the company's official website to hear management's detailed commentary on business growth and outlook.

Earnings conference call held on April 23, 2026, at 18:00 hrs IST.
Covers financial performance for the quarter and full year ended March 31, 2026.
Recording is available on the company's website under the investor updates section.
Disclosure made in compliance with Regulation 30 and 46 of SEBI Listing Regulations.

💡 Investors should listen to the recording to gain insights into management's strategy regarding AUM growth and market share trends. This will help in understanding the underlying drivers of the FY26 financial results.

UTI AMC FY26 Core Revenue Up 7% to ₹1,539 Cr; Proposes ₹40 Dividend Per Share

🟡 NEUTRAL ⭐ 8/10

EARNINGS 📅 23 Apr 2026, 06:37 PM

UTI AMC reported an 11% YoY growth in Group AUM to ₹23.42 lakh crore for FY26, driven by strong performance in passive and equity segments. While consolidated PAT fell 45% to ₹404 crore due to lower fair value gains and ₹109 crore in exceptional VRS-related costs, core revenue from operations grew a steady 7% to ₹1,539 crore. The company maintains a robust shareholder return policy, proposing a dividend of ₹40 per share, reflecting a 95% payout ratio. Despite a Q4 loss caused by mark-to-market hits, normalized core PAT for the quarter remained stable at ₹99 crore.

Total Group AUM reached ₹23.42 lakh crore, marking an 11% YoY increase as of March 2026.
Core Revenue from Sale of Services grew 7% YoY to ₹1,539 crore for the full financial year.
Proposed a final dividend of ₹40 per share, maintaining a high dividend payout ratio of 95%.
Passive AUM (ETFs & Index funds) demonstrated strong growth of 24.86% YoY to ₹1.77 lakh crore.
FY26 profitability was impacted by one-time exceptional items totaling ₹109 crore related to VRS and pension settlements.

💡 Investors should look past the volatile headline PAT, which was affected by non-cash MTM losses and one-time VRS costs, and focus on the stable core revenue growth. The high dividend yield and dominant position in the growing passive fund segment make it a steady play for income-seeking investors.

UTI AMC Recommends ₹40 Final Dividend; FY26 Standalone Net Profit at ₹539.75 Crore

🟡 NEUTRAL ⭐ 8/10

DIVIDEND 📅 23 Apr 2026, 06:00 PM

UTI Asset Management Company has recommended a final dividend of ₹40 per equity share for FY26, subject to shareholder approval. The company reported a standalone net profit of ₹539.75 crore for the full year ended March 31, 2026, compared to ₹653.52 crore in the previous year. Profitability was significantly impacted by a one-time exceptional item of ₹108.49 crore related to a Voluntary Retirement Scheme (VRS) and Labour Codes. Despite the profit dip, revenue from operations remained stable at ₹1,475.54 crore for the fiscal year.

Recommended a final dividend of ₹40 per equity share for the financial year 2025-26.
FY26 standalone net profit decreased by 17.4% to ₹539.75 crore from ₹653.52 crore in FY25.
Q4 FY26 standalone profit stood at ₹33.72 crore, down from ₹124.02 crore in the year-ago period.
Recognized an exceptional expense of ₹108.49 crore in FY26 due to VRS 2025 and Labour Code impacts.
Total standalone revenue from operations for FY26 grew marginally to ₹1,475.54 crore from ₹1,449.21 crore.

💡 Investors should note the high dividend payout but evaluate the underlying profit decline caused by one-time VRS costs. Long-term outlook remains tied to AUM growth and operational efficiency post-restructuring.

UTIAMC FY26 PAT at ₹539.75 Cr; Recommends Final Dividend of ₹40 Per Share

🟡 NEUTRAL ⭐ 8/10

EARNINGS 📅 23 Apr 2026, 05:40 PM

UTI Asset Management Company reported a standalone profit after tax of ₹539.75 crore for FY26, down from ₹653.52 crore in the previous fiscal year. The earnings were significantly impacted by an exceptional item of ₹108.49 crore related to a Voluntary Retirement Scheme (VRS) and Labour Code adjustments. Despite the lower profit, the company maintained a strong shareholder payout, recommending a final dividend of ₹40 per share. Annual revenue from operations saw a marginal increase to ₹1,475.54 crore compared to ₹1,449.21 crore in FY25.

Recommended a final dividend of ₹40 per equity share for the financial year ended March 31, 2026.
Standalone Profit After Tax (PAT) for FY26 stood at ₹539.75 crore, a 17.4% decline year-on-year.
Q4 FY26 standalone PAT dropped sharply to ₹33.72 crore from ₹124.02 crore in the year-ago period.
Reported an exceptional expense of ₹108.49 crore on account of VRS 2025 and Labour Codes.
Full-year revenue from operations grew slightly to ₹1,475.54 crore from ₹1,449.21 crore.

💡 Investors should look past the one-time VRS impact to assess core operational efficiency, while the high dividend yield remains a positive for income-seeking portfolios.

UTI AMC to Host Q4 & FY26 Earnings Conference Call on April 23, 2026

🟡 NEUTRAL ⭐ 4/10

EARNINGS 📅 01 Apr 2026, 05:43 PM

UTI Asset Management Company Limited has scheduled its earnings conference call to discuss financial results for the quarter and full fiscal year ended March 31, 2026. The call is slated for Thursday, April 23, 2026, at 18:00 hrs IST. Senior leadership, including the MD & CEO Vetri Subramaniam and CFO Vinay Lakhotia, will be present to address investor queries. This is a routine disclosure following the end of the financial year to provide transparency on operational and financial performance.

Earnings call scheduled for April 23, 2026, at 6:00 PM IST regarding FY26 results.
Management representation includes MD & CEO Vetri Subramaniam and CFO Vinay Lakhotia.
Universal access numbers for the call are +91 22 6280 1341 and +91 22 7115 8242.
DiamondPass registration is available to bypass operator waiting times for participants.

💡 Investors should attend or review the transcript of this call to understand the company's AUM growth trajectory and margin outlook for the next fiscal year. This event is critical for assessing the fundamental health of the AMC business post-FY26.

UTIAMC Board Meeting on April 23 to Approve FY26 Results and Consider Dividend

🟡 NEUTRAL ⭐ 4/10

BOARD_MEETING 📅 20 Mar 2026, 03:02 PM

UTI Asset Management Company has scheduled a board meeting on April 23, 2026, to approve audited standalone and consolidated financial results for the quarter and full year ending March 31, 2026. The board will also evaluate a potential dividend recommendation for the financial year 2025-26. Consequently, the trading window for designated persons will be closed from April 1, 2026, until April 25, 2026. This is a standard regulatory procedure ahead of the annual earnings announcement.

Board meeting scheduled for April 23, 2026, to review Q4 and full-year FY26 performance.
The company will consider recommending a dividend for the financial year ending March 31, 2026.
Trading window for designated persons and relatives closed from April 1 to April 25, 2026.
PAN of designated persons frozen as of March 20, 2026, in compliance with SEBI insider trading norms.

💡 Investors should treat this as a routine regulatory update and wait for the April 23 results to assess the company's AUM growth and dividend payout ratio.

UTI AMC to Meet Anand Rathi Analysts on March 17, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 11 Mar 2026, 04:07 PM

UTI Asset Management Company Limited (UTIAMC) has scheduled a one-on-one meeting with Anand Rathi Share and Stock Brokers Limited. The meeting is slated for March 17, 2026, at 16:00 hrs IST at the company's corporate office in Mumbai. This interaction is part of the company's regular engagement with institutional investors and analysts. The company has confirmed that no unpublished price sensitive information (UPSI) will be shared during this meeting.

One-on-one meeting scheduled with Anand Rathi Share and Stock Brokers Limited on March 17, 2026.
The meeting will be held in person at the UTI AMC Corporate Office in BKC, Mumbai.
Interaction involves senior management of UTI Asset Management Company Limited.
Disclosure made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

💡 No immediate action is required as this is a routine investor interaction. Investors may look for any post-meeting disclosures or presentation materials that might be uploaded to the exchanges.

UTI AMC Allots 906 Equity Shares Under ESOP Scheme

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 09 Mar 2026, 12:41 PM

UTI Asset Management Company Limited has approved the allotment of 906 equity shares following the exercise of options under its 2007 Employee Stock Option Scheme. This allotment increases the company's total paid-up share capital from 12,85,19,130 to 12,85,20,036 equity shares. The financial impact of this issuance is negligible given the extremely small number of shares relative to the total equity base. The new shares will rank pari-passu with existing equity shares in all respects.

Allotment of 906 equity shares of face value ₹10 each
Issued under the 'UTI AMC Employee Stock Option Scheme – 2007'
Total paid-up share capital increased to ₹1,28,52,00,360
Total outstanding shares now stand at 12,85,20,036

💡 No action is required as this is a routine administrative update with minimal dilution. Investors should remain focused on the company's AUM growth and core financial performance.

UTI AMC Schedules One-on-One Meeting with Mirabilis Investment Trust on March 12

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 09 Mar 2026, 11:55 AM

UTI Asset Management Company Limited (UTIAMC) has announced a scheduled meeting with Mirabilis Investment Trust. The one-on-one interaction is slated for March 12, 2026, at 12:00 hrs IST at the company's Mumbai corporate office. Senior management will lead the discussion, focusing on general business updates. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during this session.

One-on-one meeting scheduled with Mirabilis Investment Trust for March 12, 2026
The meeting will take place in person at the Corporate Office in BKC, Mumbai
Senior management of UTI AMC will represent the company during the interaction
The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared
Disclosure made under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements

💡 This is a routine regulatory filing for an investor meeting; no immediate action is required. Investors should continue to monitor the company's Assets Under Management (AUM) growth and market share trends.

UTI AMC to Meet Pari Washington Company Advisors on March 5, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 27 Feb 2026, 04:18 PM

UTI Asset Management Company Limited has scheduled a one-on-one meeting with Pari Washington Company Advisors Private Limited. The meeting is slated for March 5, 2026, at 16:00 hrs IST via video conference. Senior management will participate in the discussion, which is part of the company's regular investor relations activities. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during this interaction.

One-on-one meeting scheduled with Pari Washington Company Advisors Private Limited on March 5, 2026.
The interaction will take place at 16:00 hrs IST through a video conference call.
The meeting is conducted in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.
Company confirms that no unpublished price sensitive information will be disclosed during the session.

💡 No immediate action is required as this is a routine investor meeting. Investors may monitor for any subsequent investor presentations or transcripts if made available by the company.

UTI AMC Schedules One-on-One Meeting with Motilal Oswal for March 4, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 20 Feb 2026, 10:40 AM

UTI Asset Management Company Limited (UTIAMC) has announced a scheduled interaction with Motilal Oswal Financial Services Limited. The meeting is slated for March 4, 2026, at 15:30 hrs IST and will be conducted in person at the company's Mumbai corporate office. This is a one-on-one session involving senior management to discuss business updates within regulatory frameworks. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during the meeting.

One-on-one meeting scheduled with Motilal Oswal Financial Services on March 4, 2026.
The meeting will take place at 15:30 hrs IST at the Corporate Office in BKC, Mumbai.
Senior management will represent UTI AMC in this institutional investor interaction.
The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be disclosed.

💡 This is a routine investor relations activity; shareholders should look for subsequent research reports from the brokerage for potential insights. No immediate portfolio changes are recommended based on this announcement alone.

UTI AMC Reconstitutes Board Committees Following Change in MD & CEO

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 16 Feb 2026, 05:48 PM

UTI Asset Management Company has announced the reconstitution of two key board-level committees effective February 16, 2026. This move follows the appointment of Mr. Vetri Subramaniam as the new Managing Director & Chief Executive Officer, who will now serve as a member on both committees. The Corporate Social Responsibility & ESG Committee will be chaired by Ms. Vishakha R M, while the Unitholder Protection Committee will be led by Ms. P V Bharathi. These changes ensure compliance with SEBI Listing Regulations and internal governance standards.

Reconstitution of CSR & ESG Committee and Unitholder Protection Committee effective from February 16, 2026.
New MD & CEO Vetri Subramaniam inducted as a member into both reconstituted committees.
Ms. Vishakha R M, an Independent Director, appointed as Chairperson of the 4-member CSR & ESG Committee.
Ms. P V Bharathi, an Independent Director, appointed as Chairperson of the 5-member Unitholder Protection Committee.
Changes follow SEBI Master Circular dated January 30, 2026, and internal leadership transitions.

💡 This is a routine governance update following a leadership change and requires no immediate action. Investors should continue to monitor the company's performance under the new MD & CEO.

View All UTIAMC Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Core Revenue from Sale of Services grew 8% YoY to INR 769 Cr in H1 FY26. However, Total Revenue from Operations declined 10% YoY to INR 965 Cr, primarily driven by a 50% decrease in Net Gain on fair value changes (M2M gains) which fell from INR 332 Cr to INR 167 Cr. Interest and Dividend income grew 16% YoY to INR 22 Cr.

Geographic Revenue Split

UTI AMC has a presence in 698 districts in India. A significant focus is on B30 (Beyond Top 30) cities, where 205 out of 255 UTI Financial Centres (80%) are located. International revenue is supported by offices in Singapore, London, Paris, Dubai, and New York.

Profitability Margins

PAT Margins compressed significantly to 27% in Q2 FY26 compared to 44% in Q2 FY25. This was caused by a 38% YoY surge in Employee Benefit Expenses (INR 159 Cr in Q2 FY26) and a 91% drop in M2M gains for the quarter. H1 FY26 PAT Margin stood at 36% vs 46% in H1 FY25.

EBITDA Margin

Core EBITDA (excluding M2M and non-operating income) declined 6% YoY in H1 FY26. Consolidated EBITDA declined 26% YoY due to higher operating expenses and lower treasury gains. Core PAT for H1 FY26 was INR 228 Cr, down 8% YoY, though normalized Core PAT (adjusting for one-offs) grew 1% YoY to INR 248 Cr.

Capital Expenditure

Not explicitly disclosed as a single INR Cr figure, but the company is investing in digital transformation, evidenced by a 17.97% increase in digital purchase transactions to 52.74 lakh and the expansion of the New York and DIFC offices.

Credit Rating & Borrowing

UTI AMC maintains a superior liquidity position with access to sanctioned bank facilities of INR 15,525 Cr, including INR 4,000 Cr fund-based and INR 11,450 Cr intraday facilities. It utilizes TREPS for overnight borrowing to manage temporary mismatches.

⚙️ Operational Drivers

Raw Materials

Human Capital (Employee Costs) represents the primary 'raw material' cost, accounting for 29.8% of total H1 FY26 revenue (INR 288 Cr).

Import Sources

Not applicable as UTI AMC is a financial services firm; however, it sources global investment advisory talent through its offices in the USA, UK, UAE, and Singapore.

Key Suppliers

Not applicable; primary dependencies are on ~75,000 distributors and digital platform providers for fund distribution.

Capacity Expansion

Total Group AUM stood at INR 22,41,837 Cr as of September 30, 2025, growing 11.18% YoY. UTI MF QAAUM reached INR 3,78,413 Cr, a 10.47% YoY increase. The company is expanding its 'Alternatives' capacity with the launch of SDOF IV in August 2025.

Raw Material Costs

Employee Benefit Expenses rose 26% YoY in H1 FY26 to INR 288 Cr. This increase is driven by a one-time INR 25 Cr charge for VRS/family pension revisions and regular increments to retain the investment team.

Manufacturing Efficiency

Digital adoption efficiency: 95.11% of total transactions are now digital. Folio count stands at 1.36 crore, reflecting high retail reach efficiency.

Logistics & Distribution

Distribution is handled via 255 Financial Centres and 81 District Associates. Fee and Commission expenses remained stable at INR 2 Cr for H1 FY26.

📈 Strategic Growth

Expected Growth Rate

10-15%

Growth Strategy

Growth will be achieved through: 1) Deepening penetration in B30 cities (Tier 2/3) where 80% of centers are located. 2) Scaling the Alternatives business (SDOF series). 3) Leveraging the Pension Fund subsidiary which holds a 24.62% NPS market share. 4) New product launches like the Multi Cap Fund which added INR 1,576 Cr to AUM within months of launch.

Products & Services

Equity Mutual Funds (UTI Mastershare), Debt Mutual Funds, Liquid Funds, Retirement Solutions (NPS), Alternative Investment Funds (SDOF IV), Portfolio Management Services (PMS) for EPFO/CMPFO, and Offshore Funds.

Brand Portfolio

UTI Mutual Fund, UTI Mastershare, UTI Swatantra, UTI Multi Cap Fund, UTI Alternatives, UTI Pension Fund.

New Products/Services

UTI Multi Cap Fund (launched May 2025) contributed INR 1,576 Cr to AUM. Structured Debt Opportunities Fund IV (SDOF IV) launched in August 2025 to grow the private credit business.

Market Expansion

Expanding cross-border advisory through the New York office and seeking regulatory approvals in DIFC (Dubai) to capture global investor interest in Indian equities.

Market Share & Ranking

UTI AMC is among the top 10 AMCs in India. UTI Pension Fund manages 24.62% of the NPS Industry AUM.

Strategic Alliances

Collaborations with major banks (HDFC, Axis) and digital platforms to enhance distribution reach.

🌍 External Factors

Industry Trends

The industry is shifting toward digital-first transactions (95% for UTI) and B30 city participation. Passive funds and Multi-asset categories are growing, while the industry SIP stoppage ratio has increased to 76.27%.

Competitive Landscape

Competes with bank-backed AMCs (SBI, HDFC, ICICI) and new-age digital AMCs. UTI differentiates through its strong presence in the Pension and Alternative segments.

Competitive Moat

Moat is built on being the 'Oldest Mutual Fund in India' with high brand trust and a massive distribution network of 75,000 partners. Sustainability is driven by the sticky nature of SIP AUM (INR 42,267 Cr).

Macro Economic Sensitivity

Highly sensitive to capital market performance and retail sentiment. Industry SIP contributions reached a record INR 29,361 Cr in September 2025, supporting UTI's INR 2,338 Cr quarterly SIP inflow.

Consumer Behavior

Increasing preference for Systematic Investment Plans (SIPs) and digital transaction modes (17.97% YoY growth in digital purchases).

Geopolitical Risks

Global expansion in London, Paris, and New York exposes the firm to international regulatory shifts and cross-border capital flow restrictions.

⚖️ Regulatory & Governance

Industry Regulations

Governed by SEBI (Mutual Funds) Regulations, SEBI (Portfolio Managers) Regulations, and PFRDA for pension funds. New certification requirements for SIF (Specialist Investment Funds) distribution impact sales training.

Environmental Compliance

ESG principles are being embedded across the firm; UTI SDOF II & III have well-defined ESG policies. Specific compliance costs not disclosed.

Taxation Policy Impact

Effective tax rate is standard corporate rate; a deferred tax asset may be created due to the 5-year amortization of VRS costs under the Income Tax Act.

Legal Contingencies

A one-time financial impact of INR 25 Cr was accounted for in Q2 FY26 related to the revision of family pension benefits under the VRS package.

⚠️ Risk Analysis

Key Uncertainties

Market risk on treasury investments (INR 3,860 Cr) and AUM-linked fee income. A significant market correction could impact PAT by over 20% due to the high equity mix (69%).

Geographic Concentration Risk

Domestic-heavy, but diversified across 698 districts. No single region concentration disclosed.

Third Party Dependencies

High dependency on independent financial advisors and national distributors for the INR 2,338 Cr quarterly SIP mobilization.

Technology Obsolescence Risk

Mitigated by high digital adoption (95% of transactions) and a dedicated Digital Transformation Committee.

Credit & Counterparty Risk

Exposure in debt schemes is monitored via a dedicated Risk Management Team; one passive breach in a debt scheme (10% limit) was recently rebalanced within SEBI timelines.